- Bupa Platinum consultant
- Fee assured
- Verified account
- Open Referral network
Offers
- Face-to-face consultations
- Video and telephone consultations
- Home chemotherapy
About me
Dr Tim Illidge is an internationally recognised expert in the management of lymphoma, who has led and been involved with many early phase and late clinical trials.
Tim is involved with the central steering group of the NCRI lymphoma group and has represented the UK at numerous international meetings and workshops in lymphoma.
Completing a highly prestigious Cancer Research UK senior clinical research fellowship between 1999-2009, and holding the post of Senior Fulbright Fellow at Stanford university, California, Tim was appointed Professor of Oncology at the University of Manchester in 2004 and is currently Head of Division of Cancer Sciences at the university of Manchester, based at the Christie Hospital.
Tim leads a translational research group that is devoted to developing new anti-cancer treatments.
Areas of interest
Lymphoma; Hodgkin's disease
Medical secretaries
- Deniz Valiantis
- 0161 918 7162
- d.valiantis@nhs.net
Information for healthcare professionals (Bupa patients only, last 12 months)
-
X0003
Clinical supervision and planning for the delivery of chemotherapy and/or systemic anti-cancer therapy for 1-21 days - (5-50)
The Christie Clinic (5-50)
-
X0007
Clinical supervision of external beam radiotherapy, up to and including 15 fractions or part thereof - (1-5)
The Christie Clinic (1-5)